Walter N Hittelman Selected Research

Walter N Hittelman Research Topics

Disease

37	Neoplasms (Cancer) 01/2021 - 05/2002
5	Breast Neoplasms (Breast Cancer) 11/2014 - 02/2006
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 02/2007
4	Squamous Cell Carcinoma of Head and Neck 01/2019 - 05/2002
4	Melanoma (Melanoma, Malignant) 07/2013 - 01/2006
4	Esophageal Neoplasms (Esophageal Cancer) 12/2006 - 02/2006
4	Neoplasm Metastasis (Metastasis) 11/2006 - 12/2005
3	Chromosome Aberrations (Chromosome Abnormalities) 12/2019 - 07/2004
3	Carcinogenesis 12/2005 - 02/2003
2	Mouth Neoplasms (Oral Cancer) 01/2019 - 11/2017
2	Hypersensitivity (Allergy) 01/2018 - 06/2015
2	Neuralgia (Stump Neuralgia) 01/2016 - 06/2015
2	Ovarian Neoplasms (Ovarian Cancer) 04/2014 - 01/2003
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2012 - 02/2007
2	Hyperplasia 08/2011 - 04/2005
2	Hypoxia (Hypoxemia) 10/2010 - 09/2009
2	Adenocarcinoma 02/2007 - 12/2005
2	Genomic Instability 02/2007 - 04/2003
2	Carcinoma (Carcinomatosis) 11/2006 - 02/2006
2	Chromosomal Instability (Chromosome Stability) 12/2005 - 05/2005
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016
1	Pain (Aches) 06/2015
1	Necrosis 04/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2012
1	Hyperalgesia 05/2012

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2003
6	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 07/2004
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2002
5	Cyclin D1IBA 08/2011 - 02/2003
4	TWEAK ReceptorIBA 11/2014 - 07/2011
4	Immunotoxins (Immunotoxin)IBA 07/2013 - 01/2012
3	Phosphotransferases (Kinase)IBA 01/2021 - 02/2006
3	Peptides (Polypeptides)IBA 04/2014 - 01/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011 - 02/2006
3	LigandsIBA 08/2011 - 02/2007
3	FenretinideIBA 01/2009 - 09/2002
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 07/2011
2	Serine Proteases (Serine Protease)IBA 07/2019 - 10/2013
2	Granzymes (Granzyme)IBA 07/2019 - 10/2013
2	Small Interfering RNA (siRNA)IBA 06/2015 - 04/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014 - 08/2011
2	Trastuzumab (Herceptin)FDA Link 07/2013 - 06/2013
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2013 - 07/2011
2	BLyS receptorIBA 09/2012 - 02/2007
2	SurvivinIBA 09/2012 - 05/2005
2	rGel-BLyS fusion toxinIBA 08/2012 - 02/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2012 - 01/2003
2	Gelonium multiflorum GEL proteinIBA 08/2011 - 02/2007
2	Adenine FDA LinkGeneric 02/2007 - 05/2002
2	NF-kappa B (NF-kB)IBA 11/2006 - 02/2006
2	retinamideIBA 05/2006 - 09/2002
2	RetinoidsIBA 05/2006 - 02/2003
2	TOR Serine-Threonine KinasesIBA 02/2006 - 04/2005
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 02/2006 - 01/2003
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2021
1	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA 01/2021
1	2'- cyano- 2'- deoxyarabinofuranosylcytosineIBA 12/2019
1	ThiosemicarbazonesIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	adavosertibIBA 11/2017
1	Vorinostat FDA Link 11/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2016
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Vinca AlkaloidsIBA 01/2016
1	Pemetrexed (MTA)FDA Link 01/2016
1	Taxoids (Taxanes)IBA 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	ChloridesIBA 01/2016
1	Vincristine (Oncovin)FDA LinkGeneric 01/2016
1	InflammasomesIBA 06/2015
1	Cytokine TWEAKIBA 11/2014
1	N- phenylacetoaminomethylene- DL- p- nitrophenylalanine (A 101)IBA 11/2014
1	Hormones (Hormone)IBA 11/2014
1	Messenger RNA (mRNA)IBA 11/2014
1	ProlactinIBA 04/2014
1	Lapatinib (GW572016)FDA Link 06/2013
1	Indicators and Reagents (Reagents)IBA 04/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013
1	Cell Surface ReceptorsIBA 04/2013
1	Bortezomib (Velcade)FDA Link 08/2012
1	Therapeutic UsesIBA 08/2012
1	Antineoplastic Agents (Antineoplastics)IBA 05/2012
1	CannabinoidsIBA 05/2012
1	Single-Chain AntibodiesIBA 01/2012
1	Tyrosine Kinase InhibitorsIBA 08/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2011
1	AmphiregulinIBA 08/2011

Therapy/Procedure

12	Therapeutics 01/2018 - 02/2003
4	Drug Therapy (Chemotherapy) 01/2019 - 08/2006
3	Chemoprevention 12/2005 - 09/2002
2	Radiotherapy 09/2009 - 05/2002
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2019
1	Spinal Injections 06/2015
1	Intravenous Administration 06/2013